Next Article in Journal
Effect of Adding Midazolam to Dual Prophylaxis for Preventing Postoperative Nausea and Vomiting
Previous Article in Journal
Altered mRNA Expression of Interleukin-1 Receptors in Myocardial Tissue of Patients with Left Ventricular Assist Device Support
 
 
Article
Peer-Review Record

Validating Consensus-Defined Severity Grading of Lymphatic Complications after Kidney Transplant

J. Clin. Med. 2021, 10(21), 4858; https://doi.org/10.3390/jcm10214858
by Mohammadsadegh Sabagh 1, Sara Mohammadi 1, Ali Ramouz 1, Elias Khajeh 1, Omid Ghamarnejad 1, Christian Morath 2, Markus Mieth 1, Yakup Kulu 1, Martin Zeier 2, Arianeb Mehrabi 1,* and Mohammad Golriz 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
J. Clin. Med. 2021, 10(21), 4858; https://doi.org/10.3390/jcm10214858
Submission received: 1 October 2021 / Revised: 15 October 2021 / Accepted: 19 October 2021 / Published: 22 October 2021
(This article belongs to the Section Nephrology & Urology)

Round 1

Reviewer 1 Report

This is a very interesting paper on lymphoceles after kidney transplantation.

The authors report on a cohort of 587 kidney transplant patients, of whom 90 developed a lymphocele.

86% of the lymphoceles were managed non-surgically.

The authors then validated the lymphocele classification by Mehrabi et al.

The manuscipt is very detailed, as are the tables.

I have the following comments:

  • the authors might consider adding table captions
  • I do not quite understand the statistics in Table 3 - some short explantations at the bottom of the table would be good
  • the discussion is quite long and may be shortened

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

This paper examines the validity and effectiveness of the classification of post-kidney transplant lymphocele proposed by Mehrabi et al.

However, the following addition should be required.

  1.  Whether the kidney transplant procedure, especially the kidney graft procedure, is ligating the tissue around the kidney or the tissue around the ureter? Or, do the authors use LigaSure in place of ligation. Similarly, recipient surgery should describe in detail how the lymphatic vessels around the arteries are treated.
  2. .Grading depends on the success of conservative therapy and is unlikely to be suitable for future study of the etiology of lymphocele.
  3. Evidence that this classification is clinically valid should be provided.
  4. Recently, it has been pointed out that mTOR inhibitors (Certican) may cause lymphocele, so immunosuppressive methods for each group should be added. 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

The author takes the requests from the reviewers seriously, responds to them and corrects them. Although it has little scientific basis, it has some clinical usefulness. 

Back to TopTop